Kyto Biopharma Inc., Research Foundation of the State University of New York deal

Kyto received a license to the foundation's IP covering the vitamin B12 receptor. Kyto is developing a humanized version of its murine mAbTCR23 antibody, which targets the vitamin B12 receptor and is...